Our models can answer questions that would be logistically difficult outside of an in silico setting:
- Predict outcomes from novel combination therapies
- Simulate complex scenarios involving first-line treatment, non-response, and then second line or combination therapies
- Predict long-term effects beyond protocol duration
- Predict efficacy for alternative treatment strategies (dose, duration, schedule, route)
- Optimize timing for interventions